Cargando…

Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II

BACKGROUND: We attempted to determine whether the inflammatory pathway HMGB1-TLR4 and the downstream pro-inflammatory cytokines is upregulated in focal cortical dysplasia (FCD) type II and whether there is a correlation between the TLR4 upregulation and disease duration or frequency of epileptic sei...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhongbin, Liu, Qingzhu, Liu, Ming, Wang, Hui, Dong, Ying, Ji, Taoyun, Liu, Xiaoyan, Jiang, Yuwu, Cai, Lixin, Wu, Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791174/
https://www.ncbi.nlm.nih.gov/pubmed/29382328
http://dx.doi.org/10.1186/s12974-018-1078-8
_version_ 1783296576414810112
author Zhang, Zhongbin
Liu, Qingzhu
Liu, Ming
Wang, Hui
Dong, Ying
Ji, Taoyun
Liu, Xiaoyan
Jiang, Yuwu
Cai, Lixin
Wu, Ye
author_facet Zhang, Zhongbin
Liu, Qingzhu
Liu, Ming
Wang, Hui
Dong, Ying
Ji, Taoyun
Liu, Xiaoyan
Jiang, Yuwu
Cai, Lixin
Wu, Ye
author_sort Zhang, Zhongbin
collection PubMed
description BACKGROUND: We attempted to determine whether the inflammatory pathway HMGB1-TLR4 and the downstream pro-inflammatory cytokines is upregulated in focal cortical dysplasia (FCD) type II and whether there is a correlation between the TLR4 upregulation and disease duration or frequency of epileptic seizures. METHODS: FCD type II and peri-FCD paired tissues resected from eight children with refractory epilepsy were collected. Through real-time qPCR, Western blot, and co-immunoprecipitation, we examined the differences between FCD lesions and peri-FCD tissues with respect to mRNA expression, protein expression, and protein interaction in HMGB1-TLR4 pathway biomarker and downstream pro-inflammatory factors in whole brain tissue. Then, we used immunofluorescence to examine the difference between FCD lesions and peri-FCD tissues with respect to protein expression and intracellular distribution of HMGB1-TLR4 pathway biomarker in neurons, astrocytes, and oligodendrocytes. Correlation between level of TLR4 expression and disease duration or frequency of epileptic seizures in patients was also analyzed. RESULTS: The protein expression levels of TLR4, cytoplasm HMGB1, TLR4/MyD88 complex, ubiquitination of TRAF6, p-IKK, p-IκB-α, p-NF-κB p65, and IL-1β and TNF-α in lesion tissues were significantly higher than those in peri-FCD controls. Total mRNA expression levels of TLR4, IL-1β, and TNF-α in lesion tissues were significantly higher than those in peri-FCD controls, but HMGB1 had no significant change. In neurons and astrocytes inside the lesions, the expression of TLR4 protein was significantly higher than that in peri-FCD tissues, and HMGB1 was mainly expressed in the cytoplasm, while expressed in the nuclei in peri-FCD tissues. But in oligodendrocytes, there was no upregulation of HMGB1-TLR4 pathway in both lesions and peri-FCD tissues. We did not identify the correlation between the level of TLR4 activation and disease duration or frequency of epileptic seizures. CONCLUSION: The HMGB1-TLR4 pathway was upregulated in the neurons and astrocytes inside FCD type II lesions, which led to an increase in the release of downstream pro-inflammatory cytokines. Correlation between the level of TLR4 activation and duration or frequency of epileptic seizures was not identified.
format Online
Article
Text
id pubmed-5791174
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57911742018-02-08 Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II Zhang, Zhongbin Liu, Qingzhu Liu, Ming Wang, Hui Dong, Ying Ji, Taoyun Liu, Xiaoyan Jiang, Yuwu Cai, Lixin Wu, Ye J Neuroinflammation Research BACKGROUND: We attempted to determine whether the inflammatory pathway HMGB1-TLR4 and the downstream pro-inflammatory cytokines is upregulated in focal cortical dysplasia (FCD) type II and whether there is a correlation between the TLR4 upregulation and disease duration or frequency of epileptic seizures. METHODS: FCD type II and peri-FCD paired tissues resected from eight children with refractory epilepsy were collected. Through real-time qPCR, Western blot, and co-immunoprecipitation, we examined the differences between FCD lesions and peri-FCD tissues with respect to mRNA expression, protein expression, and protein interaction in HMGB1-TLR4 pathway biomarker and downstream pro-inflammatory factors in whole brain tissue. Then, we used immunofluorescence to examine the difference between FCD lesions and peri-FCD tissues with respect to protein expression and intracellular distribution of HMGB1-TLR4 pathway biomarker in neurons, astrocytes, and oligodendrocytes. Correlation between level of TLR4 expression and disease duration or frequency of epileptic seizures in patients was also analyzed. RESULTS: The protein expression levels of TLR4, cytoplasm HMGB1, TLR4/MyD88 complex, ubiquitination of TRAF6, p-IKK, p-IκB-α, p-NF-κB p65, and IL-1β and TNF-α in lesion tissues were significantly higher than those in peri-FCD controls. Total mRNA expression levels of TLR4, IL-1β, and TNF-α in lesion tissues were significantly higher than those in peri-FCD controls, but HMGB1 had no significant change. In neurons and astrocytes inside the lesions, the expression of TLR4 protein was significantly higher than that in peri-FCD tissues, and HMGB1 was mainly expressed in the cytoplasm, while expressed in the nuclei in peri-FCD tissues. But in oligodendrocytes, there was no upregulation of HMGB1-TLR4 pathway in both lesions and peri-FCD tissues. We did not identify the correlation between the level of TLR4 activation and disease duration or frequency of epileptic seizures. CONCLUSION: The HMGB1-TLR4 pathway was upregulated in the neurons and astrocytes inside FCD type II lesions, which led to an increase in the release of downstream pro-inflammatory cytokines. Correlation between the level of TLR4 activation and duration or frequency of epileptic seizures was not identified. BioMed Central 2018-01-30 /pmc/articles/PMC5791174/ /pubmed/29382328 http://dx.doi.org/10.1186/s12974-018-1078-8 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhang, Zhongbin
Liu, Qingzhu
Liu, Ming
Wang, Hui
Dong, Ying
Ji, Taoyun
Liu, Xiaoyan
Jiang, Yuwu
Cai, Lixin
Wu, Ye
Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II
title Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II
title_full Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II
title_fullStr Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II
title_full_unstemmed Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II
title_short Upregulation of HMGB1-TLR4 inflammatory pathway in focal cortical dysplasia type II
title_sort upregulation of hmgb1-tlr4 inflammatory pathway in focal cortical dysplasia type ii
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791174/
https://www.ncbi.nlm.nih.gov/pubmed/29382328
http://dx.doi.org/10.1186/s12974-018-1078-8
work_keys_str_mv AT zhangzhongbin upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii
AT liuqingzhu upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii
AT liuming upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii
AT wanghui upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii
AT dongying upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii
AT jitaoyun upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii
AT liuxiaoyan upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii
AT jiangyuwu upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii
AT cailixin upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii
AT wuye upregulationofhmgb1tlr4inflammatorypathwayinfocalcorticaldysplasiatypeii